Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Industry association suggests ways Cancer Drugs Fund could spike NICE's guns

This article was originally published in Scrip

Executive Summary

The Association of the British Pharmaceutical Industry (ABPI) has suggested as part of its latest advice to the UK government that the £200 million-a-year Cancer Drugs Fund could be used to pay for treatments that are not yet available through the UK National Health System because they are stuck in appraisals at the UK's health technology agency, the National Centre for health and Clinical Excellence (NICE). The proposal, which was delivered as part of the ABPI's response to a consultation on the Cancer Drugs Fund which closes on January 19, sounds innocuous. However, if adopted, it could make a significant dent in the Cancer Drugs Fund because the current average length of appraisals of oncology compounds at NICE is nearly 30 months (see Box below).

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC011534

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel